pubmed:abstractText |
Most studies of men undergoing treatment for prostate cancer examine physical symptoms as predictors of Quality of Life (QOL). However, symptoms vary by treatment modality in this population, and psychosocial variables, shown to be important to QOL, have rarely been examined. Litwin noted a need for analysis of QOL data in men treated for prostate cancer with different modes of therapy, as studies focusing on specific treatments will increase the homogeneity of research findings.
|
pubmed:affiliation |
College of Nursing, Rutgers, The State University of New Jersey, Newark, NJ 07102, USA. eliselev@andromeda.rutgers.edu
|